P1101
A23-301
Phase 3 small_molecule completed
Quick answer
P1101 for Polycythemia Vera (PV) is a Phase 3 program (small_molecule) at PharmaEssentia with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PharmaEssentia
- Indication
- Polycythemia Vera (PV)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed